BOOK
Current Therapy in Colon and Rectal Surgery E-Book
Victor W. Fazio | James M. Church | Conor P Delaney | Ravi P Kiran
(2016)
Additional Information
Book Details
Abstract
For more than 25 years, Current Therapy in Colon and Rectal Surgery has been the go-to resource for preparing for the American Board of Surgery certification exam. Following in this tradition, the 3rd Edition offers a comprehensive, contemporary summary of treatment options for colorectal diseases, with a focus on practical clinical science and applications. In a single, portable volume, you’ll find complete coverage of new diagnostic modalities, medical therapeutics, and surgical treatment options, including minimally invasive surgery. Easy to read and digest, it provides a quick consultation with experts on the essentials of colon and rectal surgery.
- Consult this title for a quick overview before you enter the OR, and use it as a review tool for board certification and recertification.
- Nearly 100 succinct chapters, just 3 or 4 pages each, written by leading experts in colorectal surgery.
- Five chapters devoted exclusively to different aspects of rectal cancer.
- Other key topics include minimally invasive surgery, reparative surgery, maturing outcomes, and managing surgical risk.
- New chapters focus on hot topics such as intestinal transplants, enhanced recovery programs, and the management of peristomal hernias.
- Updated information on the molecular biology of colorectal cancer and its implications for therapy.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
IFC | ES1 | ||
Current therapy in colon and rectal surgery | i | ||
Copyright | ii | ||
Dedication | iii | ||
Contributors | v | ||
Preface to the third edition | xiii | ||
Acknowledgments | xiv | ||
Contents | xv | ||
1 - ANAL AND PERIANAL REGION | 1 | ||
1 - Anatomy and Physiology of the Colon, Rectum, and Anal Canal* | 3 | ||
ANATOMY OF THE COLON AND RECTUM | 3 | ||
Colon | 3 | ||
Course and Peritoneal Coverings | 3 | ||
Rectum | 3 | ||
Peritoneal Relations and Fascial Attachments | 3 | ||
ARTERIAL SUPPLY | 4 | ||
Superior Mesenteric Artery | 4 | ||
Inferior Mesenteric Artery | 4 | ||
Collateral Circulation | 5 | ||
VENOUS DRAINAGE | 5 | ||
Superior Mesenteric Vein | 5 | ||
Inferior Mesenteric Vein | 5 | ||
LYMPHATIC DRAINAGE | 5 | ||
INNERVATION | 5 | ||
COLON AND RECTUM PHYSIOLOGY | 6 | ||
Colonic Physiology | 6 | ||
Absorption and Secretion | 6 | ||
Digestion | 6 | ||
Propulsion and Storage | 6 | ||
ANAL CANAL ANATOMY | 7 | ||
Lining | 7 | ||
Muscles of the Anorectal Region | 8 | ||
Perineal Body | 8 | ||
Pelvic Floor Muscles | 8 | ||
Innervation of the Anus | 8 | ||
Motor Innervation | 8 | ||
Sensory Innervation | 9 | ||
Arterial Supply of the Anus | 9 | ||
Lymphatic Drainage of the Anus | 9 | ||
Venous Drainage of the Anus | 9 | ||
ANAL CANAL PHYSIOLOGY | 9 | ||
Mechanisms of Continence | 9 | ||
Defecation | 9 | ||
Physiologic Testing | 9 | ||
Anal Manometry | 9 | ||
Defecography by Fluoroscopy or Magnetic Resonance Imaging | 10 | ||
Balloon Expulsion Test | 10 | ||
Saline Continence Test | 10 | ||
Rectal Compliance | 10 | ||
Electromyography | 10 | ||
Nerve Stimulation Techniques | 10 | ||
Suggested Reading | 11 | ||
2 - Hemorrhoids | 12 | ||
EXTERNAL HEMORRHOIDS | 12 | ||
ANATOMY AND ETIOLOGY OF INTERNAL HEMORRHOIDS | 12 | ||
CLINICAL EVALUATION | 12 | ||
NONEXCISIONAL OPTIONS | 13 | ||
Medical Management | 13 | ||
Sclerotherapy | 13 | ||
Energy-Based Destruction | 13 | ||
Hemorrhoidal Ligation with Rubber Bands | 13 | ||
EXCISIONAL HEMORRHOIDECTOMY | 13 | ||
Instrumentation for Excisional Hemmorrhoidectomy | 14 | ||
PROCEDURE FOR PROLAPSING HEMORRHOIDS (STAPLED HEMMORHOIDOPEXY) | 14 | ||
DOPPLER-GUIDED HEMORRHOIDAL DEARTERIALIZATION | 14 | ||
POSTOPERATIVE MANAGEMENT AFTER HEMORRHOID SURGERY | 14 | ||
CONCLUSION | 15 | ||
Suggested Reading | 15 | ||
3 - Chronic Anal Fissure | 16 | ||
INTRODUCTION | 16 | ||
DIAGNOSIS | 16 | ||
PATHOPHYSIOLOGY | 16 | ||
High-Pressure Chronic Anal Fissure | 16 | ||
Low- and Normal-Pressure Chronic Anal Fissure | 16 | ||
MANAGEMENT | 17 | ||
Topical Creams | 17 | ||
Botulinum Toxin | 17 | ||
Fissurectomy | 17 | ||
Cutaneous Advancement Flap | 18 | ||
Lateral Internal Sphincterotomy | 18 | ||
Surgical Technique | 18 | ||
Risk of Incontinence | 18 | ||
Tailored Sphincterotomy | 18 | ||
Treatment of Low/Normal Pressure Chronic Anal Fissure | 18 | ||
SUMMARY: CHOICE OF TREATMENT | 19 | ||
Suggested Reading | 19 | ||
4 - Anorectal Abscess | 21 | ||
SURGICAL ANATOMY | 21 | ||
ETIOLOGY | 21 | ||
NATURAL HISTORY OF THE DISEASE AND SPREAD PATHWAYS | 21 | ||
CLINICAL FEATURES | 21 | ||
Perianal Abscess | 21 | ||
Ischiorectal Abscess | 21 | ||
Intersphincteric Abscess | 22 | ||
Supralevator Abscess | 22 | ||
Deep Postanal Abscess | 22 | ||
Submucosal Abscess | 22 | ||
DIAGNOSIS | 22 | ||
Treatment of Anorectal Abscesses | 22 | ||
Large Abscesses | 22 | ||
Searching for a Fistula | 22 | ||
Ischiorectal Abscess | 23 | ||
Intersphincteric Abscesses | 23 | ||
Supralevator Abscess | 23 | ||
Submucosal Abscess | 23 | ||
Role of Antibiotics and Biopsy | 23 | ||
Postoperative Care | 23 | ||
Complications | 23 | ||
RECURRENCE AND THE DEVELOPMENT OF FISTULA IN ANO | 23 | ||
Suggested Reading | 23 | ||
5 - Anal Fistula | 24 | ||
INTRODUCTION | 24 | ||
ETIOLOGY | 24 | ||
CLASSIFICATION | 24 | ||
PRESENTATION | 24 | ||
DIAGNOSIS AND EVALUATION | 24 | ||
Preparation and Examination | 25 | ||
2 - RECTAL AND PARARECTAL REGION | 91 | ||
19 - Fecal Incontinence | 93 | ||
INTRODUCTION AND INCIDENCE | 93 | ||
CAUSES | 93 | ||
ASSESSMENT | 93 | ||
TREATMENT | 94 | ||
Medical Management | 94 | ||
Biofeedback | 94 | ||
Surgery | 94 | ||
Anal Sphincter Repair (Sphincteroplasty) | 94 | ||
Postanal Repair | 95 | ||
Anal Encirclement | 95 | ||
Muscle Transposition | 95 | ||
Sacral Nerve Stimulation | 95 | ||
Posterior Tibial Nerve Stimulation | 96 | ||
Continence Enemas | 96 | ||
Stem Cells, Bulking Agents, and Other Techniques | 96 | ||
Fecal Diversion | 96 | ||
CONCLUSIONS | 96 | ||
Suggested Readings | 97 | ||
20 - Rectal Stricture: Etiology and Management | 98 | ||
DEFINITION | 98 | ||
PRESENTATION AND DIAGNOSIS | 98 | ||
ETIOLOGY | 98 | ||
BENIGN RECTAL STRICTURES | 98 | ||
Rectal Strictures Related to Inflammatory Bowel Disease | 98 | ||
MALIGNANT RECTAL STRICTURES | 100 | ||
SUMMARY | 100 | ||
Suggested Readings | 100 | ||
21 - Management of Fecal Impaction | 102 | ||
INTRODUCTION | 102 | ||
ETIOPATHOLOGY | 102 | ||
Presentation | 102 | ||
DIAGNOSIS | 103 | ||
TREATMENT | 103 | ||
Medical Treatment | 103 | ||
Digital Evacuation | 103 | ||
Enemas and Colonic Lavage | 103 | ||
Oral Solutions | 104 | ||
Stool Softeners | 104 | ||
Laxatives | 105 | ||
Endoscopic Disimpaction | 105 | ||
SURGERY | 105 | ||
Acute | 105 | ||
Chronic | 105 | ||
PREVENTION | 105 | ||
CONCLUSION | 105 | ||
Suggested Reading | 105 | ||
22 - Rectal Prolapse | 107 | ||
INTRODUCTION | 107 | ||
PATHOPHYSIOLOGY | 107 | ||
CLINICAL FEATURES | 107 | ||
PREOPERATIVE CONSIDERATIONS | 107 | ||
SURGICAL OPTIONS | 108 | ||
Perineal Repairs | 108 | ||
Abdominal Procedures | 108 | ||
Recommendations | 109 | ||
Problems | 109 | ||
MANAGEMENT OF RECURRENT PROLAPSE | 109 | ||
Suggested Reading | 109 | ||
23 - Solitary Rectal Ulcer Syndrome | 111 | ||
INTRODUCTION | 111 | ||
CAUSE | 111 | ||
PATHOPHYSIOLOGY | 111 | ||
CLINICAL FEATURES | 111 | ||
DIAGNOSIS | 112 | ||
MANAGEMENT | 112 | ||
Nonoperative Management | 112 | ||
Surgery | 113 | ||
CONCLUSIONS | 113 | ||
Suggested Reading | 113 | ||
24 - Rectocele | 114 | ||
DEFINITION | 114 | ||
CAUSES | 114 | ||
SYMPTOMS | 114 | ||
DIAGNOSIS | 114 | ||
MANAGEMENT | 115 | ||
SURGICAL TREATMENT | 115 | ||
Transanal Repairs | 115 | ||
Transvaginal Repairs | 115 | ||
Transperineal Repairs | 116 | ||
Comparison of Approaches | 116 | ||
SUMMARY | 116 | ||
Suggested Reading | 117 | ||
25 - Rectal Foreign Bodies | 118 | ||
EPIDEMIOLOGY | 118 | ||
EVALUATION | 118 | ||
CLASSIFICATION | 118 | ||
American Association for the Surgery of Trauma Rectal Organ Injury Scale | 118 | ||
Location of the Foreign Body | 119 | ||
Intraperitoneal or Extraperitoneal | 119 | ||
EXTRACTION | 119 | ||
MANAGEMENT | 119 | ||
POSTEXTRACTION CARE | 120 | ||
Suggested Reading | 120 | ||
26 - Diagnosis and Management of Sacral and Retrorectal Tumors | 121 | ||
INTRODUCTION | 121 | ||
ANATOMY OF THE RETRORECTAL SPACE | 121 | ||
CLASSIFICATION SYSTEMS | 121 | ||
CONGENITAL/DEVELOPMENTAL LESIONS | 122 | ||
Germ Cell Tumors | 122 | ||
Tailgut Cysts | 123 | ||
Duplication Cysts | 123 | ||
Anterior Sacral Meningocele | 124 | ||
Chordoma | 124 | ||
Osseous Tumors | 125 | ||
Neurogenic Tumors | 127 | ||
Nonosseous Mesenchymal Tumors | 127 | ||
INFLAMMATORY LESIONS | 127 | ||
METASTATIC LESIONS | 127 | ||
DIAGNOSTIC APPROACHES TO SACRAL AND RETRORECTAL TUMORS | 127 | ||
OPERATIVE APPROACHES | 128 | ||
SUMMARY | 130 | ||
Suggested Reading | 130 | ||
27 - Management of Rectal Villous Tumors | 132 | ||
INTRODUCTION | 132 | ||
RECTAL ANATOMY AND PHYSIOLOGY | 132 | ||
CLINICALLY SIGNIFICANT ASSOCIATIONS OF RECTAL FUNCTION | 132 | ||
THERAPEUTIC OPTIONS RESULTING FROM THE LOCATION OF THE RECTUM | 132 | ||
RECTAL VILLOUS TUMORS | 132 | ||
ASSESSING THE LESION FOR CANCER | 132 | ||
TREATMENT | 132 | ||
Endoscopic Polypectomy | 132 | ||
Transanal Excision | 133 | ||
Transanal Endoscopic Microsurgery/Transanal Minimally Invasive Surgery | 134 | ||
Delorme Procedure | 134 | ||
Trans-sacral Resection | 134 | ||
Anterior Resection | 134 | ||
FOLLOW-UP | 134 | ||
Suggested Reading | 134 | ||
28 - Preoperative Evaluation of the Patient with Rectal Cancer: Staging and Strategy | 135 | ||
INTRODUCTION | 135 | ||
CLINICAL ASSESSMENT | 135 | ||
History | 135 | ||
Physical Examination | 135 | ||
ENDOSCOPIC EVALUATION AND BIOPSY | 135 | ||
PREOPERATIVE STAGING WITH IMAGING MODALITIES | 136 | ||
Locoregional Evaluation | 136 | ||
Tumor Stage and the Circumferential Resection Margin | 136 | ||
Nodal Staging | 137 | ||
Extramural Venous Invasion | 138 | ||
Locoregional Imaging Synoptic Reports | 138 | ||
Distant Metastatic Evaluation | 138 | ||
Serum Tumor Markers | 139 | ||
ROLE OF MULTIDISCIPLINARY CANCER CONFERENCES | 139 | ||
Suggested Readings | 140 | ||
29 - Cancer of the Rectum: Neoadjuvant Therapy | 141 | ||
INTRODUCTION | 141 | ||
RADIOTHERAPY TRIALS | 141 | ||
ROLE OF CIRCUMFERENTIAL RESECTION MARGIN | 141 | ||
MULTIMODALITY TREATMENT APPROACHES | 141 | ||
RANDOMIZED TRIALS COMPARING NEOADJUVANT SHORT-COURSE RADIOTHERAPY WITH CHEMOTHERAPY–LONG-COURSE RADIOTHERAPY | 142 | ||
RADIATION TREATMENT VOLUMES | 142 | ||
RADIATION-RELATED TOXICITIES | 142 | ||
OTHER PERIOPERATIVE RADIATION TREATMENT OPTIONS | 142 | ||
Boosting the Dose | 142 | ||
INTRAOPERATIVE RADIATION THERAPY | 144 | ||
INTENSITY-MODULATED RADIATION THERAPY | 144 | ||
HIGH-DOSE-RATE ENDORECTAL BRACHYTHERAPY | 144 | ||
SUMMARY | 144 | ||
Suggested Reading | 144 | ||
30 - Cancer of the Rectum: Operative Management | 146 | ||
INTRODUCTION | 146 | ||
KEY ANATOMIC POINTS | 146 | ||
PRESURGICAL PATIENT PREPARATION AND EVALUATION | 146 | ||
PREOPERATIVE DECISION MAKING | 147 | ||
Deciding Between an Open or Laparoscopic Approach | 147 | ||
Should a Stapled or Hand-Sewn Restorative Procedure Be Performed? | 147 | ||
SURGICAL PRINCIPLES | 147 | ||
Total Mesorectal Excision | 147 | ||
Ligation of the Inferior Mesenteric Artery | 147 | ||
Distal Resection Margins | 147 | ||
Choice of Anastomotic Configuration | 147 | ||
Drainage | 148 | ||
Diverting Stoma | 148 | ||
KEY STEPS OF SURGICAL PROCEDURES | 148 | ||
Low Anterior Resection | 148 | ||
Positioning and Equipment | 148 | ||
Trocar Placement | 148 | ||
Exposure of the Operating Field | 148 | ||
Identification of Inferior Mesenteric Vessels and Left Ureter | 148 | ||
Division of the Vessels and Splenic Flexure Mobilization | 148 | ||
Mobilization and Division of the Rectum | 148 | ||
Exteriorization of the Specimen | 149 | ||
Creation of the Anastomosis | 149 | ||
Desufflation and Closure of Trocar Incisions | 149 | ||
Abdominoperineal Resection | 149 | ||
Closure of the Anal Opening | 149 | ||
Mobilization of the Rectum | 149 | ||
Proximal Division of the Left Colon | 149 | ||
Perineal Dissection and Exteriorization | 149 | ||
Closure of Pelvic Wound and Trocar Incisions and Creation of the Colostomy | 149 | ||
PELVIC EXENTERATION | 150 | ||
Surgical Approaches | 150 | ||
Assessment Before Exenteration | 150 | ||
Signs of Irresectability | 150 | ||
Sacrectomy | 150 | ||
Pelvic Sidewall Disease | 150 | ||
Anterior Compartment/Urogenital Disease | 150 | ||
Central Recurrence | 150 | ||
Bladder Reconstruction | 150 | ||
Perineal Reconstruction | 150 | ||
OUTCOMES: SURVIVAL AND LOCAL RECURRENCE | 150 | ||
Suggested Reading | 151 | ||
31 - Local Treatment of Rectal Cancer | 152 | ||
INTRODUCTION | 152 | ||
PREOPERATIVE EVALUATION | 152 | ||
INITIAL SELECTION | 153 | ||
SURGICAL TECHNIQUE | 153 | ||
Patient Preparation | 153 | ||
Transanal Excision | 153 | ||
Transanal Endoscopic Microsurgery/Transanal Endoscopic Operation | 153 | ||
Transanal Minimally Invasive Surgery | 154 | ||
MANAGEMENT OF THE SPECIMEN | 154 | ||
FOLLOW-UP | 154 | ||
RESULTS | 154 | ||
Local Excision for T1N0 Rectal Cancer | 154 | ||
Local Excision for T2N0 Rectal Cancer | 154 | ||
Salvage Resection after Local Excision | 155 | ||
ALTERNATIVE TO LOCAL EXCISION: ENDOCAVITARY CONTACT RADIATION | 155 | ||
CONCLUSIONS: ALGORITHM FOR TREATMENT BY LOCAL EXCISION | 156 | ||
32 - Locally Recurrent Rectal Cancer: Management and Follow-up | 157 | ||
INTRODUCTION | 157 | ||
NOMENCLATURE OF PELVIC RECURRENCE | 157 | ||
CLINICAL EVALUATION FOR SUSPECTED PELVIC RECURRENCE | 157 | ||
MANAGEMENT OF PELVIC RECURRENCE | 158 | ||
Category I: Asymptomatic Local and Distant Recurrence | 158 | ||
Category II: Symptomatic Local Recurrence in the Presence of Distant Disease | 158 | ||
Category III: Unresectable, Isolated Local Recurrence | 158 | ||
Category IV: Resectable Isolated Local Recurrence | 158 | ||
Axial Recurrences | 159 | ||
Anterior Recurrences | 159 | ||
Posterior Recurrences | 159 | ||
Lateral Recurrences | 159 | ||
THE ROLE OF CHEMORADIATION FOR PELVIC RECURRENCE | 159 | ||
PREOPERATIVE AND INTRAOPERATIVE CONSIDERATIONS | 159 | ||
RECONSTRUCTION OPTIONS FOR PERINEAL DEFECTS | 160 | ||
SUMMARY | 160 | ||
Suggested Reading | 160 | ||
33 - Perineal Hernia | 162 | ||
INTRODUCTION | 162 | ||
THERAPY | 162 | ||
Patient Selection | 162 | ||
Preoperative Preparation | 162 | ||
Procedures | 162 | ||
Alternative Methods | 163 | ||
Postoperative Care | 163 | ||
Complications | 163 | ||
PREVENTION | 164 | ||
SUMMARY | 164 | ||
Suggested Reading | 164 | ||
3 - COLON | 165 | ||
34 - Preoperative Preparation of the Patient for Colon and Rectal Surgery | 167 | ||
INTRODUCTION | 167 | ||
RISK ASSESSMENT | 167 | ||
CARDIOVASCULAR ASSESSMENT AND PREOPERATIVE MANAGEMENT | 167 | ||
PREOPERATIVE PULMONARY ASSESSMENT AND MANAGEMENT | 169 | ||
MANAGEMENT OF PATIENTS RECEIVING ANTITHROMBOTIC THERAPY | 170 | ||
MANAGEMENT OF PREOPERATIVE ANEMIA | 171 | ||
MANAGEMENT OF PREOPERATIVE MALNUTRITION | 172 | ||
Suggested Reading | 173 | ||
35 - Medical Treatment of Ulcerative Colitis and Other Colitides | 174 | ||
ULCERATIVE COLITIS | 174 | ||
Diagnosis | 174 | ||
Treatment | 174 | ||
Diet | 174 | ||
5-Aminosalycilic Acid | 174 | ||
Mild to Moderate Ulcerative Colitis | 174 | ||
Proctitis and Left-Sided Ulcerative Colitis | 176 | ||
Left-Sided Disease | 176 | ||
Extensive Disease | 177 | ||
Lack of Response to 5-Aminosalycilic Acid | 177 | ||
Oral Budesonide | 177 | ||
Corticosteroids | 177 | ||
Severe Ulcerative Colitis | 177 | ||
Cyclosporine | 177 | ||
Azathioprine and 6-Mercaptopurine | 178 | ||
Biologic Agents | 178 | ||
Infliximab | 178 | ||
Loss of Response. It is known that antibodies can develop in patients receiving anti-TNF-α agents with a loss of response to tre... | 178 | ||
Infusion Reactions. Mild infusion reactions occur in 5% to 13% of patients, but severe infusion reactions requiring infliximab d... | 179 | ||
Delayed Reactions. Delayed reactions occur 3 to 12 days after the administration of infliximab. These reactions result from the ... | 179 | ||
Adalimumab | 179 | ||
Golimumab | 179 | ||
How to Choose an Anti-TNF-α Agent | 179 | ||
Complications | 179 | ||
What to Do Before Starting Anti-TNF-α Therapy | 179 | ||
What to Do Once Treatment with an Anti-TNF-α Agent Is Started | 179 | ||
Antiadhesion Molecules | 180 | ||
Alternative Therapies | 180 | ||
Nicotine | 180 | ||
Clinical Scenarios | 180 | ||
Quiescent Disease | 180 | ||
Fulminant or Toxic Colitis | 180 | ||
General Recommendations for Patients with Severe Ulcerative Colitis | 181 | ||
Test for C. difficile Toxin A and B | 181 | ||
Flexible Sigmoidoscopy with Biopsies | 181 | ||
Deep Vein Thrombosis Prophylaxis | 181 | ||
Evaluate for Tuberculosis and Hepatitis B | 181 | ||
Avoid Narcotics and Antidiarrheal Medications | 181 | ||
Do Not Use Antibiotics | 181 | ||
Diet as Tolerated | 181 | ||
Perform Close Observation and Consult Colorectal Surgery upon Admission | 181 | ||
Vaccinations | 181 | ||
Pregnancy | 181 | ||
Cancer Risk | 181 | ||
Colorectal Cancer Prevention | 183 | ||
OTHER COLITIDES | 183 | ||
Microscopic Colitis | 183 | ||
Diversion Colitis | 183 | ||
Radiation Colopathy | 184 | ||
Drug-Induced Colitis | 184 | ||
Suggested Reading | 184 | ||
36 - Chronic Ulcerative Colitis: Surgical Options | 186 | ||
INTRODUCTION | 186 | ||
EVOLUTION OF SURGERY FOR ULCERATIVE COLITIS | 186 | ||
INDICATIONS FOR SURGERY IN PERSONS WITH ULCERATIVE COLITIS | 186 | ||
OPERATIONS FOR ULCERATIVE COLITIS | 186 | ||
Ileostomy | 186 | ||
Straight Ileoanal Anastomosis | 186 | ||
Subtotal Colectomy | 186 | ||
Abdominal Colectomy with Ileorectal Anastomosis | 187 | ||
Ileostomy and Blowhole Colostomy | 187 | ||
Total Proctocolectomy and Ileostomy | 187 | ||
Proctectomy Surgical Technique | 187 | ||
Continent Ileostomy | 187 | ||
Restorative Proctocolectomy | 188 | ||
Pouch Configuration and Anastomosis | 188 | ||
Staging the Procedure | 188 | ||
Technique of Creation of an Ileoanal J Pouch | 188 | ||
Problems with Reach of the Pouch | 188 | ||
OUTCOMES OF ILEAL POUCH–ANAL ANASTOMOSIS | 189 | ||
Complications after Ileal Pouch–Anal Anastomosis | 189 | ||
Overall Quality of Life | 189 | ||
Function of the Pouch | 189 | ||
Pouchitis | 189 | ||
Pouch Failure | 189 | ||
Pouch Fistula | 189 | ||
Risk of Carcinoma | 189 | ||
Fertility, Sexual Problems, and Obstetric Outcome | 189 | ||
Extraintestinal Manifestations | 189 | ||
Quantification of Risk for Pouch Failure after Ileal Pouch Anal Anastomosis Surgery | 190 | ||
Salvage of the Failed Pelvic Pouch | 190 | ||
Suggested Reading | 190 | ||
37 - Management of Acute Toxic Colitis and Megacolon | 191 | ||
INTRODUCTION | 191 | ||
EPIDEMIOLOGY AND ETIOLOGY | 191 | ||
PATHOPHYSIOLOGY | 191 | ||
PRESENTATION | 191 | ||
DIAGNOSIS | 191 | ||
EVALUATION | 192 | ||
MEDICAL MANAGEMENT | 193 | ||
SURGICAL MANAGEMENT | 195 | ||
Indications for Surgery | 195 | ||
Surgical Options | 195 | ||
CONCLUSION | 196 | ||
Suggested Reading | 196 | ||
38 - Pelvic Pouch: Complications and Their Management | 197 | ||
INTRODUCTION | 197 | ||
POUCH DYSFUNCTION | 197 | ||
INTRAOPERATIVE COMPLICATIONS | 197 | ||
POSTOPERATIVE COMPLICATIONS | 197 | ||
Pelvis Sepsis and Anastomotic Leak | 198 | ||
Postoperative Bleeding from the Pouch | 198 | ||
Pouch-Perineal and Pouch-Vaginal Fistulae | 198 | ||
Pouch Sinus | 198 | ||
Leak from the Tip of the “J” | 199 | ||
Pouch Prolapse | 199 | ||
Pouchitis and Cuffitis | 199 | ||
Crohn Disease of the Pouch | 199 | ||
Outlet Dysfunction | 199 | ||
Cancer of the Pouch | 199 | ||
Pouch Failure | 199 | ||
ABDOMINOPERINEAL APPROACH FOR POUCH SALVAGE | 199 | ||
Operative Technique | 200 | ||
Suggested Reading | 200 | ||
39 - Pouchitis and Functional Complications of the Pelvic Pouch | 201 | ||
INTRODUCTION | 201 | ||
POUCHITIS | 201 | ||
ETIOLOGY AND PATHOGENESIS | 201 | ||
Genetic Factors | 201 | ||
The Microbiome | 201 | ||
Mucosal Immunity | 201 | ||
DIAGNOSIS | 201 | ||
Categories of Pouchitis | 202 | ||
TREATMENT | 202 | ||
IRRITABLE POUCH SYNDROME | 202 | ||
OTHER FUNCTIONAL DISORDERS | 203 | ||
CONCLUSIONS | 203 | ||
Suggested Reading | 203 | ||
40 - Continent Ileostomy | 204 | ||
INTRODUCTION | 204 | ||
EVOLUTION OF THE CONTINENT ILEOSTOMY | 204 | ||
TECHNIQUES TO BETTER FIX THE VALVE | 204 | ||
POUCH DESIGN MODIFICATIONS | 204 | ||
CURRENT INDICATIONS AND CONTRAINDICATIONS | 205 | ||
CURRENT SURGICAL TECHNIQUE AND STATUS | 205 | ||
Key Surgical Points | 205 | ||
Typical Pouch Function | 206 | ||
COMPLICATIONS OF A CONTINENT ILEOSTOMY | 207 | ||
Perioperative Complications | 207 | ||
Early Complications | 207 | ||
Late Complications | 207 | ||
Valve Slippage | 207 | ||
Parastomal Hernia | 207 | ||
Crohn Disease | 207 | ||
Pouchitis | 207 | ||
Valve Stenosis | 207 | ||
Pouch Excision | 207 | ||
WHAT TO DO WHEN A PATIENT PRESENTS ACUTELY WITH THE INABILITY TO INTUBATE HIS OR HER POUCH | 208 | ||
CONCLUSIONS | 208 | ||
Suggested Reading | 208 | ||
41 - Unhealed Perineal Wound | 209 | ||
INTRODUCTION | 209 | ||
SPECIAL SITUATIONS LEADING TO AN UNHEALED PERINEAL WOUND | 209 | ||
CAUSES | 209 | ||
Technical Factors | 209 | ||
Patient-Specific Factors | 209 | ||
Crohn Disease | 209 | ||
Radiation | 209 | ||
PREVENTION | 210 | ||
Preoperative | 210 | ||
Intraoperative | 210 | ||
Reconstruction of the Perineum with a Flap | 210 | ||
DIAGNOSIS/WORKUP | 211 | ||
NONOPERATIVE TREATMENT | 211 | ||
OPERATIVE MANAGEMENT | 211 | ||
SUMMARY | 212 | ||
Suggested Reading | 212 | ||
42 - Medical Management of Crohn Disease | 213 | ||
INTRODUCTION | 213 | ||
MEDICAL THERAPIES | 213 | ||
5-Aminosalicylates | 213 | ||
Antibiotics | 213 | ||
Corticosteroids | 213 | ||
Immunomodulators | 213 | ||
Biologic Agents | 214 | ||
Combination Therapy | 214 | ||
PERIANAL AND FISTULIZING CROHN DISEASE | 215 | ||
APPROACH TO MANAGEMENT OF CROHN DISEASE | 215 | ||
SURGERY | 216 | ||
POSTOPERATIVE RECURRENCE | 216 | ||
SMOKING | 216 | ||
NUTRITION | 216 | ||
Suggested Reading | 216 | ||
43 - Management of Crohn Colitis | 217 | ||
MEDICAL MANAGEMENT | 217 | ||
OPERATIVE INDICATIONS | 217 | ||
PREOPERATIVE CONSIDERATIONS | 217 | ||
OPERATIVE APPROACH | 217 | ||
OPERATIVE OPTIONS | 218 | ||
Disease of the Colon Alone | 218 | ||
Disease of the Rectum Alone | 218 | ||
Disease of the Colon and Rectum | 218 | ||
SPECIAL SITUATIONS | 219 | ||
Medications | 219 | ||
Abscess | 219 | ||
Severe Colitis | 219 | ||
Growth Retardation | 220 | ||
Fistula | 220 | ||
Neoplasia | 220 | ||
OUTCOME | 220 | ||
SUMMARY | 221 | ||
Suggested Reading | 221 | ||
44 - Management of Perianal Crohn Disease | 222 | ||
INTRODUCTION | 222 | ||
PATHOPHYSIOLOGY | 222 | ||
OTHER CONSIDERATIONS | 222 | ||
PRESENTATIONS | 222 | ||
Anal Sepsis | 222 | ||
Anal Tags | 222 | ||
Fissures | 222 | ||
Stenosis | 223 | ||
Perianal Skin Irritation | 223 | ||
Internal Hemorrhoidal Prolapse | 223 | ||
TREATMENT OF SEPSIS: ABSCESS AND FISTULA | 223 | ||
RECTO/ANOVAGINAL FISTULA | 224 | ||
OTHER MANIFESTATION OF PERIANAL CROHN DISEASE | 224 | ||
SUMMARY | 224 | ||
Suggested Reading | 225 | ||
45 - Cecal Ulcer | 226 | ||
INTRODUCTION | 226 | ||
CAUSES | 226 | ||
DIAGNOSIS | 226 | ||
MANAGEMENT | 227 | ||
CONCLUSION | 227 | ||
Suggested Reading | 227 | ||
46 - Pseudomembranous Clostridium Difficile Colitis | 228 | ||
INTRODUCTION | 228 | ||
PRESENTATION OF CLOSTRIDIUM DIFFICILE INFECTION | 228 | ||
DIAGNOSIS | 228 | ||
MEDICAL MANAGEMENT | 229 | ||
SURGICAL MANAGEMENT | 229 | ||
CONCLUSION | 230 | ||
Suggested Reading | 230 | ||
47 - Cytomegalovirus Ileocolitis and Kaposi Sarcoma in HIV/AIDS | 231 | ||
INTRODUCTION | 231 | ||
CYTOMEGALOVIRUS COLITIS | 231 | ||
SURGERY | 232 | ||
KAPOSI SARCOMA | 232 | ||
Suggested Reading | 233 | ||
48 - Diagnosis and Management of Acute Colonic Diverticulitis | 234 | ||
INTRODUCTION | 234 | ||
PRESENTATION | 234 | ||
DIAGNOSTIC EVALUATION | 234 | ||
MEDICAL MANAGEMENT | 235 | ||
SURGICAL MANAGEMENT | 235 | ||
Surgery | 237 | ||
Suggested Reading | 237 | ||
49 - Surgical Treatment of Diverticulitis and its Complications | 239 | ||
INTRODUCTION | 239 | ||
UNDERSTANDING DIVERTICULAR DISEASE AND ITS MANAGEMENT | 239 | ||
ACUTE UNCOMPLICATED DIVERTICULITIS | 239 | ||
Who Requires Elective Surgery after Uncomplicated Diverticulitis? | 239 | ||
COMPLICATED DIVERTICULITIS | 240 | ||
Acute Diverticulitis Complicated by Abscess Formation: Converting an Emergency Situation into a Semi-Elective Procedure | 240 | ||
Acute Diverticulitis Complicated by Purulent or Feculent Peritonitis: Surgical Options in the Emergency Setting | 241 | ||
Hartmann Procedure and Reversal | 241 | ||
COMPLICATED DIVERTICULITIS WITH FISTULA FORMATION | 242 | ||
Colovesical Fistulas: Diagnosis and Management | 242 | ||
Colovaginal Fistulas: Diagnosis and Management | 242 | ||
Colocutaneous Fistulas: Diagnosis and Management | 242 | ||
ACUTE COLONIC OBSTRUCTION: PATIENT SELECTION FOR EMERGENT VERSUS SEMI-ELECTIVE OPERATIONS | 242 | ||
RECURRENT DIVERTICULITIS IN PATIENTS WHO HAVE PREVIOUSLY UNDERGONE RESECTION FOR DIVERTICULAR DISEASE | 243 | ||
Suggested Reading | 243 | ||
50 - Lower Gastrointestinal Hemorrhage | 244 | ||
INTRODUCTION | 244 | ||
ETIOLOGY | 244 | ||
INITIAL EVALUATION AND RESUSCITATION | 244 | ||
DIAGNOSTIC TESTING | 245 | ||
Scintigraphy | 245 | ||
Multidetector Computed Tomography | 246 | ||
Angiography | 246 | ||
Colonoscopy | 246 | ||
SURGERY | 247 | ||
THE PROBLEM PATIENT: INTERMITTENT RECURRENT GASTROINTESTINAL BLEEDING | 247 | ||
Suggested Reading | 248 | ||
51 - Large Bowel Obstruction | 249 | ||
INTRODUCTION | 249 | ||
CLINICAL AND DIAGNOSTIC EVALUATION | 249 | ||
SURGICAL MANAGEMENT | 250 | ||
MALIGNANT AND BENIGN OBSTRUCTION | 250 | ||
Right-Sided Obstruction | 251 | ||
Left-Sided Obstruction | 251 | ||
Self-Expanding Metallic Stents | 252 | ||
COLONIC VOLVULUS | 253 | ||
SIGMOID VOLVULUS | 253 | ||
CECAL VOLVULUS | 254 | ||
Suggested Reading | 254 | ||
52 - Colonic Volvulus | 255 | ||
INTRODUCTION | 255 | ||
CECAL VOLVULUS | 255 | ||
Background and Demographics | 255 | ||
Pathophysiology | 255 | ||
Signs and Symptoms | 255 | ||
Diagnostic Imaging | 255 | ||
Treatment | 255 | ||
SIGMOID VOLVULUS | 256 | ||
Background and Demographics | 256 | ||
Pathophysiology | 256 | ||
Signs and Symptoms | 256 | ||
Diagnostic Imaging | 256 | ||
Treatment | 256 | ||
TRANSVERSE COLON VOLVULUS | 258 | ||
Background and Demographics | 258 | ||
Pathophysiology | 259 | ||
Diagnostic Imaging | 259 | ||
Signs and Symptoms | 259 | ||
Treatment | 259 | ||
Suggested Readings | 259 | ||
53 - Colonic Pseudo-obstruction (Ogilvie Syndrome) | 260 | ||
INTRODUCTION | 260 | ||
EPIDEMIOLOGY | 260 | ||
ETIOLOGY | 260 | ||
SIGNS AND SYMPTOMS | 260 | ||
DIAGNOSIS | 261 | ||
TREATMENT OPTIONS | 261 | ||
Initial Management | 261 | ||
Pharmacologic Management | 261 | ||
Endoscopic Therapy | 262 | ||
Surgery | 262 | ||
SUMMARY | 262 | ||
Suggested Reading | 262 | ||
54 - Management of the Malignant Polyp | 264 | ||
INTRODUCTION | 264 | ||
BIOLOGY | 264 | ||
ASSESSMENT OF POLYPS | 264 | ||
POLYPECTOMY | 264 | ||
HISTOLOGY | 264 | ||
MARGIN | 265 | ||
NODES | 265 | ||
SURGICAL CONSIDERATIONS | 265 | ||
COMORBIDITIES | 266 | ||
SUMMARY | 266 | ||
Suggested Reading | 266 | ||
55 - Colorectal Cancer Screening and Surveillance | 267 | ||
SCREENING FOR COLORECTAL CANCER | 267 | ||
Who Should Be Screened? Determining Risk | 267 | ||
Screening Average-Risk Persons | 267 | ||
CANCER PREVENTION TESTS | 267 | ||
Colonoscopy | 267 | ||
Flexible Sigmoidoscopy | 268 | ||
Computed Tomographic Colonography | 268 | ||
CANCER DETECTION TESTS | 269 | ||
Fecal Occult Blood Tests | 269 | ||
Stool DNA | 269 | ||
SCREENING IN PERSONS AT AN ABOVE-AVERAGE RISK FOR COLORECTAL CANCER | 269 | ||
Surveillance Colonoscopy in Patients with Adenomatous Lesions at Baseline | 269 | ||
Surveillance Colonoscopy in Patients with Serrated Lesions at Baseline | 270 | ||
Surveillance Colonoscopy after Piecemeal Polypectomy | 270 | ||
Surveillance Colonoscopy after Endoscopic Resection of a Malignant Polyp | 271 | ||
Surveillance Colonoscopy in Patients with Colorectal Cancer | 271 | ||
Surveillance Colonoscopy in Patients with Inflammatory Bowel Disease | 271 | ||
Surveillance Colonoscopy in Patients with a Family History of Colorectal Cancer or Adenomatous Polyps | 271 | ||
WHEN SHOULD SCREENING AND SURVEILLANCE STOP IN THE AVERAGE-RISK POPULATION? | 271 | ||
CONCLUSION | 271 | ||
Suggested Readings | 271 | ||
56 - Molecular Genetics of Colorectal Cancer | 273 | ||
INTRODUCTION | 273 | ||
GROWTH CONTROL | 273 | ||
DNA REPAIR | 273 | ||
CLINICAL SIGNIFICANCE | 273 | ||
COMPLEXITY | 274 | ||
Suggested Reading | 274 | ||
57 - Polyposis Syndromes | 275 | ||
INTRODUCTION | 275 | ||
REGISTRIES | 275 | ||
DEFINITIONS | 275 | ||
FAMILIAL ADENOMATOUS POLYPOSIS | 275 | ||
Genetic Testing | 275 | ||
Genotype/Phenotype | 275 | ||
Colorectal Cancer in Familial Adenomatous Polyposis | 276 | ||
Surgical Options for the Large Bowel | 276 | ||
Extracolonic Manifestations | 276 | ||
Ampullary Cancer and Duodenal Adenomas | 277 | ||
Thyroid Cancer | 277 | ||
Adrenal Masses | 277 | ||
Brain Tumors | 277 | ||
Hepatoblastoma | 277 | ||
Gardner-Type Manifestations | 277 | ||
Congenital Hypertrophy of the Retinal Pigmented Epithelium | 277 | ||
Surveillance | 278 | ||
The IRA | 278 | ||
The IPAA | 278 | ||
Oligopolyposis/Attenuated Familial Adenomatous Polyposis | 278 | ||
MYH-ASSOCIATED POLYPOSIS (MAP) | 278 | ||
POLYMERASE PROOFREADING–ASSOCIATED POLYPOSIS | 279 | ||
SERRATED POLYPOSIS | 279 | ||
HAMARTOMATOUS POLYPOSES | 279 | ||
Peutz-Jegher Polyposis | 279 | ||
Juvenile Polyposis | 279 | ||
PTEN Tumor Hamartoma Syndrome | 280 | ||
HEREDITARY MIXED POLYPOSIS SYNDROME | 280 | ||
Suggested Reading | 280 | ||
58 - Desmoid Disease | 281 | ||
INTRODUCTION | 281 | ||
BIOLOGY | 281 | ||
EPIDEMIOLOGY | 281 | ||
GENETICS AND DESMOID RISK | 281 | ||
DESMOID SEVERITY: A STAGING SYSTEM | 281 | ||
MANAGEMENT | 282 | ||
Setting Expectations | 282 | ||
A Philosophy of Care | 282 | ||
Extra-abdominal Desmoid Tumors | 282 | ||
Abdominal Wall Tumors | 282 | ||
Intra-abdominal Desmoid Disease | 282 | ||
Workup | 282 | ||
Medical Treatment | 282 | ||
Role of Surgery | 283 | ||
Complications of Desmoid Disease | 283 | ||
Small Bowel Obstruction | 283 | ||
Ureteric Obstruction | 283 | ||
Abscess/Enterocutaneous Fistula | 283 | ||
Superior Mesenteric Artery Aneurysm | 284 | ||
Points about Operating on Persons with Desmoid Disease | 284 | ||
SUMMARY AND GENERAL COMMENTS ABOUT THE EFFECT OF DESMOID DISEASE ON SURGICAL STRATEGY IN FAMILIAL ADENOMATOUS POLYPOSIS | 284 | ||
Suggested Reading | 284 | ||
59 - Hereditary Nonpolyposis\rColorectal Cancer and Lynch Syndrome | 285 | ||
INTRODUCTION | 285 | ||
HISTORICAL PERSPECTIVE AND CLARIFICATION OF TERMS | 285 | ||
GENETIC AND MOLECULAR CAUSE OF LYNCH SYNDROME | 285 | ||
HISTOLOGIC FEATURES OF LYNCH TUMORS | 285 | ||
DIAGNOSING LYNCH SYNDROME | 286 | ||
Clinical Criteria | 286 | ||
Models | 286 | ||
Tumor Testing | 286 | ||
GENETIC COUNSELING AND TESTING | 287 | ||
CLINICAL MANIFESTATIONS AND MANAGEMENT | 288 | ||
COLORECTAL CANCER RISK MANAGEMENT | 288 | ||
Surveillance Colonoscopy and Polypectomy | 288 | ||
Chemoprevention | 288 | ||
Surgery | 289 | ||
Colectomy in the Absence of Cancer | 289 | ||
Treatment of Colon Cancer | 289 | ||
Rectal Cancer in Persons with Lynch Syndrome | 289 | ||
RISK MANAGEMENT OF EXTRACOLONIC MANIFESTIONS | 289 | ||
Endometrial and Ovarian Cancer | 289 | ||
Upper Gastrointestinal Tract | 290 | ||
Urinary Tract | 290 | ||
Skin Neoplasms | 290 | ||
Other Cancers | 290 | ||
CLINICAL VARIATIONS OF HNPCC AND LYNCH SYNDROME | 290 | ||
Familial Colorectal Cancer Type X | 290 | ||
Likely Lynch Syndrome: Amsterdam Criteria with a Microsatellite Instability High Colorectal Cancer, but Germline Testing Is Not ... | 290 | ||
Tumor Lynch | 291 | ||
SUMMARY | 291 | ||
Suggested Reading | 291 | ||
60 - Cancer of the Appendix and Pseudomyxoma Peritonei Syndrome | 292 | ||
INTRODUCTION | 292 | ||
PATHOLOGY OF APPENDICEAL MALIGNANT TUMORS | 292 | ||
Carcinoid Tumors | 292 | ||
Adenocarcinoid Tumors of the Appendix (Goblet Cell Carcinoid) | 292 | ||
Epithelial (Noncarcinoid) Tumors of the Appendix | 292 | ||
Mucinous Adenoma and Adenocarcinoma | 292 | ||
Nonmucinous Adenocarcinoma | 293 | ||
DIAGNOSIS OF APPENDICEAL MALIGNANT TUMORS | 293 | ||
Carcinoid | 293 | ||
Adenocarcinoma and Mucinous Adenocarcinoma | 294 | ||
Pseudomyxoma Peritonei Syndrome | 294 | ||
TREATMENT OF APPENDICEAL TUMORS | 295 | ||
Carcinoid Tumors | 295 | ||
Appendiceal Adenocarcinoma | 296 | ||
Management of Appendiceal Neoplasms with Peritoneal Dissemination | 296 | ||
Perioperative Chemotherapy | 297 | ||
Serial Debulking | 297 | ||
CYTOREDUCTIVE SURGERY AND PERIOPERATIVE CHEMOTHERAPY | 298 | ||
Survival by Completeness of Cytoreduction | 298 | ||
Survival by Histologic Assessment | 298 | ||
Survival by Prior Surgical Score | 298 | ||
Treatment of Adenocarcinoid Appendiceal Malignancy | 298 | ||
Morbidity and Mortality Rates | 299 | ||
Peritonectomy | 299 | ||
Perioperative Chemotherapy | 300 | ||
Suggested Reading | 300 | ||
61 - Surgical Management of Cancer of the Colon | 301 | ||
INTRODUCTION | 301 | ||
EPIDEMIOLOGY | 301 | ||
Prognostic Factors | 301 | ||
PREOPERATIVE EVALUATION | 301 | ||
PREOPERATIVE PREPARATION | 301 | ||
OPERATIVE PRINCIPLES AND TECHNIQUES | 302 | ||
Exploration | 302 | ||
Surgical Treatment of Right Colon Cancer | 302 | ||
Surgical Treatment of Transverse Colon Cancer | 304 | ||
Surgical Treatment of Splenic Flexure and Descending Colon Cancer | 304 | ||
Surgical Treatment of Sigmoid Colon Cancer | 305 | ||
LAPAROSCOPIC COLECTOMY | 306 | ||
SPECIAL CONSIDERATIONS | 306 | ||
Obstruction and Perforation | 306 | ||
Prophylactic Oophorectomy | 307 | ||
ASSESSMENT OF QUALITY OF COLECTOMY | 307 | ||
POSTOPERATIVE SURVEILLANCE | 307 | ||
SUMMARY | 307 | ||
Suggested Readings | 308 | ||
62 - Management of Metastatic Colorectal Cancer | 309 | ||
INTRODUCTION | 309 | ||
CHEMOTHERAPY | 309 | ||
5-Fu | 309 | ||
Capecitabine | 309 | ||
Irinotecan | 309 | ||
Oxaliplatin | 311 | ||
MAINTENANCE CHEMOTHERAPY | 311 | ||
BIOLOGIC AGENTS | 311 | ||
FIRST-LINE TARGETED OPTIONS | 312 | ||
THIRD- AND FOURTH-LINE OPTIONS | 312 | ||
OLIGOMETASTATIC DISEASE | 312 | ||
ROLE OF RESECTION OF PRIMARY LESION | 313 | ||
IMMUNOTHERAPY | 313 | ||
CONCLUSIONS | 313 | ||
Suggested Reading | 313 | ||
63 - Management of Colorectal Liver Metastasis | 314 | ||
INTRODUCTION | 314 | ||
DIAGNOSIS AND PREOPERATIVE WORKUP | 314 | ||
Imaging | 314 | ||
Serologic and Molecular Markers | 314 | ||
Histology | 314 | ||
Needle Biopsy | 314 | ||
Multidisciplinary Planning | 314 | ||
STAGING AND PROGNOSIS | 314 | ||
PROGNOSTIC SCORES | 315 | ||
TREATMENT | 315 | ||
Chemotherapy | 315 | ||
Neoadjuvant Chemotherapy for Resectable Liver Disease | 315 | ||
Neoadjuvant Chemotherapy for Unresectable Liver Disease | 315 | ||
Adjuvant Chemotherapy | 315 | ||
Hepatic Arterial Infusion | 316 | ||
Resectability | 316 | ||
Resectable Liver Disease | 316 | ||
Synchronous Liver Metastasis | 316 | ||
Unresectable Liver Disease | 317 | ||
Repeat Resections for Multiple Liver Metastases | 317 | ||
Local Ablative Therapy | 317 | ||
Radiofrequency Ablation | 317 | ||
Microwave Ablation | 318 | ||
Cryotherapy | 318 | ||
Irreversible Electroporation | 318 | ||
Colorectal Liver Metastases with Extrahepatic Spread | 318 | ||
Lung | 318 | ||
Peritoneal | 318 | ||
Lymph Node Involvement | 318 | ||
Inferior Vena Cava | 318 | ||
Recurrence | 318 | ||
SURVEILLANCE | 318 | ||
CONCLUSION | 318 | ||
Suggested Readings | 318 | ||
64 - Colorectal Metastases to the Lung | 320 | ||
INTRODUCTION | 320 | ||
INDICATIONS FOR RESECTION OF COLORECTAL METASTASES | 320 | ||
OUTCOMES OF PATIENTS UNDERGOING RESECTION AND PROGNOSTIC FACTORS | 320 | ||
LUNG AND LIVER METASTASIS | 321 | ||
SURGICAL APPROACH | 321 | ||
DEVELOPMENT OF A PROSPECTIVE RANDOMIZED TRIAL: THE PULMONARY METASTASECTOMY IN COLORECTAL CANCER TRIAL | 322 | ||
CONCLUSION | 322 | ||
Suggested Reading | 322 | ||
65 - Nonepithelial Colorectal Tumors | 323 | ||
INTRODUCTION | 323 | ||
BENIGN NONADENOMATOUS LESIONS OF THE COLON AND RECTUM | 323 | ||
Benign Lymphoid Hyperplasia | 323 | ||
Lipomas | 323 | ||
Treatment | 323 | ||
CAVERNOUS HEMANGIOMA | 323 | ||
Characteristic Features | 324 | ||
Treatment | 325 | ||
Surgery (Laparotomy/Laparoscopic) | 325 | ||
LEIOMYOMA AND LEIOMYOSARCOMA | 326 | ||
Characteristic Features | 326 | ||
Surgery | 326 | ||
PRIMARY LYMPHOMA OF THE COLON AND RECTUM | 326 | ||
SUMMARY | 327 | ||
Suggested Reading | 327 | ||
66 - Management of Colonic Ischemia | 328 | ||
INTRODUCTION | 328 | ||
ETIOLOGY AND PATHOGENESIS | 328 | ||
CLASSIFICATION | 328 | ||
CLINICAL PRESENTATION | 329 | ||
DIAGNOSIS | 330 | ||
MANAGEMENT | 330 | ||
OUTCOME | 331 | ||
SPECIAL TOPICS | 331 | ||
Ischemic Colitis after Aortic Surgery | 331 | ||
Colonic Ischemia after Cardiopulmonary Bypass | 332 | ||
Ischemic Colitis Associated with Colon Carcinoma and Obstructing Colon Lesions | 332 | ||
Total Colonic Ischemia | 332 | ||
Ischemic Proctosigmoiditis | 332 | ||
CONCLUSION | 333 | ||
Suggested Readings | 333 | ||
67 - Colon and Rectal Trauma | 334 | ||
INTRODUCTION | 334 | ||
ETIOLOGY | 334 | ||
DIAGNOSIS | 334 | ||
Physical Examination | 334 | ||
Imaging | 334 | ||
Diagnostic Peritoneal Lavage | 335 | ||
Laparoscopy | 335 | ||
TREATMENT | 336 | ||
Colon Injuries | 336 | ||
Damage Control | 337 | ||
Rectal Injuries | 338 | ||
Overview | 338 | ||
Diversion | 338 | ||
Direct Repair | 338 | ||
Drainage | 338 | ||
Distal Washout | 338 | ||
Rectal Foreign Bodies | 339 | ||
Suggested Reading | 340 | ||
68 - Endometriosis of the Colon and Rectum | 341 | ||
INTRODUCTION | 341 | ||
PAIN | 341 | ||
INFERTILITY | 341 | ||
DIAGNOSIS | 341 | ||
Physical Examination | 341 | ||
Endoscopy | 341 | ||
Imaging | 342 | ||
SURGICAL MANAGEMENT | 342 | ||
Results after Surgical Therapy | 343 | ||
Combined Medical and Surgical Therapy | 343 | ||
CONCLUSION | 343 | ||
Suggested Reading | 343 | ||
69 - Pneumatosis Cystoides Intestinalis | 345 | ||
INTRODUCTION | 345 | ||
ETIOLOGY | 345 | ||
CLASSIFICATION | 345 | ||
HISTOLOGY AND GROSS PATHOLOGY | 345 | ||
SYMPTOMS | 345 | ||
DIAGNOSIS | 346 | ||
TREATMENT | 347 | ||
Suggested Readings | 348 | ||
70 - Constipation | 349 | ||
INTRODUCTION | 349 | ||
CAUSES | 349 | ||
CLASSIFYING CONSTIPATION | 349 | ||
ASSESSMENT | 349 | ||
History | 349 | ||
Physical Examination | 350 | ||
INVESTIGATIONS | 350 | ||
TREATMENT | 351 | ||
Medical | 351 | ||
Newer Promotility Agents | 352 | ||
Biofeedback for Pelvic Floor Dyssynergia | 352 | ||
Change in Position of Defecation | 352 | ||
Surgery | 352 | ||
Outlet Obstruction Constipation | 355 | ||
Suggested Reading | 355 | ||
4 - SMALL INTESTINE | 357 | ||
71 - Small Bowel Obstruction | 359 | ||
EXTENT OF THE PROBLEM | 359 | ||
CLINICAL PRESENTATION | 359 | ||
IMAGING | 359 | ||
MRI and Ultrasound | 360 | ||
MANAGEMENT OF SMALL BOWEL OBSTRUCTION | 360 | ||
Nonadhesive Obstruction | 361 | ||
Hernias | 361 | ||
Crohn Disease | 361 | ||
Malignancy | 361 | ||
Intussusception | 361 | ||
Gallstone Ileus | 361 | ||
Bariatric Patient | 361 | ||
Surgical Technique | 361 | ||
Adhesive Obstruction | 361 | ||
Hernias | 362 | ||
Crohn Disease and Other Inflammatory Conditions | 362 | ||
Malignancy | 362 | ||
Intussusception | 363 | ||
Gallstone Ileus | 363 | ||
The Bariatric Patient | 363 | ||
Laparoscopic versus Open Lysis of Adhesions | 363 | ||
Early Postoperative Bowel Obstruction | 363 | ||
Prevention of Adhesions | 363 | ||
SUMMARY | 364 | ||
Suggested Reading | 365 | ||
72 - Medical Management of Short Bowel Syndrome | 366 | ||
INTRODUCTION | 366 | ||
ANATOMY OF SHORT BOWEL SYNDROME | 366 | ||
DIETARY MANAGEMENT OF SHORT BOWEL SYNDROME | 366 | ||
PHARMACOLOGIC TREATMENT OF SHORT BOWEL SYNDROME | 366 | ||
PARENTERAL AND ENTERAL NUTRITION | 366 | ||
HORMONAL TREATMENT FOR SHORT BOWEL SYNDROME | 369 | ||
COMPLICATIONS ASSOCIATED WITH SHORT BOWEL SYNDROME | 369 | ||
CONCLUSION | 370 | ||
Suggested Reading | 371 | ||
73 - Surgery for Gut Failure: Auto-Reconstruction and Allo-Transplantation | 372 | ||
INTRODUCTION | 372 | ||
GUT ADAPTATION | 372 | ||
MEDICAL MANAGEMENT | 372 | ||
SURGICAL REHABILITATION | 373 | ||
Strategy | 373 | ||
Autologous Reconstruction | 373 | ||
Intestinal Lengthening | 376 | ||
INTESTINAL AND MULTIVISCERAL TRANSPLANTATION | 376 | ||
Types | 376 | ||
Indications | 377 | ||
Contraindications | 378 | ||
Early Referral | 378 | ||
Transplantation Surgery | 378 | ||
Postoperative Management | 379 | ||
Current Global Activities | 380 | ||
Long-Term Survival | 380 | ||
Allograft Function | 381 | ||
Quality of Life | 381 | ||
New Insights | 382 | ||
SUMMARY | 383 | ||
Suggested Reading | 383 | ||
74 - Crohn Disease of the Duodenum, Stomach, and Esophagus | 385 | ||
INTRODUCTION | 385 | ||
CLINICAL PRESENTATION | 385 | ||
INVESTIGATIONS IN UPPER GASTROINTESTINAL CROHN DISEASE | 385 | ||
MEDICAL TREATMENT | 386 | ||
ENDOSCOPIC TREATMENT | 386 | ||
SURGERY | 386 | ||
SUMMARY | 387 | ||
Suggested Readings | 387 | ||
75 - Management of Small Bowel Crohn Disease | 388 | ||
INTRODUCTION | 388 | ||
MEDICAL MANAGEMENT | 388 | ||
INDICATIONS FOR SURGERY | 388 | ||
PREOPERATIVE CONSIDERATIONS | 388 | ||
OPERATIVE APPROACH | 388 | ||
SURGICAL OPTIONS | 389 | ||
Bypass | 389 | ||
Resection | 389 | ||
Strictureplasty | 390 | ||
SPECIAL SITUATIONS | 390 | ||
Medications | 390 | ||
Abscess | 390 | ||
Free Perforation | 390 | ||
Hemorrhage | 390 | ||
Growth Retardation | 390 | ||
Fistula | 390 | ||
Neoplasia | 390 | ||
Obstruction | 390 | ||
OUTCOME | 392 | ||
SUMMARY | 392 | ||
Selected Reading | 392 | ||
76 - Small Bowel Neoplasms | 393 | ||
INTRODUCTION | 393 | ||
PRESENTATION | 393 | ||
DIAGNOSIS | 393 | ||
MANAGEMENT | 394 | ||
Adenocarcinoma without Metastatic Disease | 394 | ||
Carcinoid Tumors | 394 | ||
Lymphomas | 395 | ||
GIST Tumors | 395 | ||
CONCLUSION | 395 | ||
ACKNOWLEDGMENT | 395 | ||
Suggested Readings | 395 | ||
77 - Neuroendocrine Tumors of the Small and Large Intestine | 396 | ||
DEFINITION | 396 | ||
INCIDENCE, EPIDEMIOLOGY, AND RESEARCH | 396 | ||
CLINICAL PRESENTATION | 397 | ||
DIAGNOSIS | 397 | ||
CLASSIFICATION | 398 | ||
SURGICAL TREATMENT | 398 | ||
Small Intestine | 398 | ||
Appendix | 398 | ||
Colon | 398 | ||
Rectum | 398 | ||
Locally Advanced and Metastatic Disease | 399 | ||
Hedinger Syndrome | 402 | ||
ADJUVANT THERAPY | 402 | ||
FOLLOW-UP | 403 | ||
PROGNOSIS | 403 | ||
Suggested Reading | 403 | ||
78 - Enterocutaneous Fistulas | 404 | ||
INTRODUCTION | 404 | ||
PATHOGENESIS | 404 | ||
GENERAL ASPECTS OF CARE | 404 | ||
COMPLICATIONS | 404 | ||
PLAN OF CARE | 404 | ||
Prevention | 404 | ||
Stabilization | 406 | ||
Wound Care | 406 | ||
Nutritional Support | 407 | ||
Nasogastric Tubes and Other Drainage Tubes | 407 | ||
Protection of the Gastric, Duodenal, and Upper Gastrointestinal Tract Mucosa from Ulceration | 407 | ||
Other Supplements | 407 | ||
Investigation/Elucidation | 407 | ||
Therapeutic Decisions | 407 | ||
Will It Close? | 407 | ||
The Decision to Operate | 407 | ||
Definitive Therapy | 408 | ||
Timing of Surgery | 408 | ||
Surgery | 408 | ||
Choice of Incision | 408 | ||
The Operation Itself | 408 | ||
Anastomosis | 409 | ||
Abdominal Wound Closure | 409 | ||
What Type of Operation Should One Undertake? | 409 | ||
Gastrostomy and Feeding Jejunostomy | 410 | ||
The Healing Phase | 410 | ||
Fibrin Glue | 410 | ||
Short Bowel Syndrome | 410 | ||
PROGNOSIS | 410 | ||
Suggested Reading | 411 | ||
79 - Acute and Chronic Mesenteric Ischemia | 412 | ||
INTRODUCTION | 412 | ||
ACUTE MESENTERIC ISCHEMIA | 412 | ||
Clinical Presentation | 412 | ||
Evaluation | 413 | ||
Treatment | 413 | ||
SMA Embolus | 414 | ||
SMA Thrombus | 414 | ||
Mesenteric Venous Thrombosis | 414 | ||
Nonocclusive Mesenteric Ischemia | 414 | ||
Bowel Viability | 414 | ||
Laparoscopy | 415 | ||
CHRONIC MESENTERIC ISCHEMIA | 415 | ||
Presentation | 416 | ||
Evaluation | 416 | ||
Operative Treatment | 416 | ||
Angioplasty | 416 | ||
CONCLUSION | 417 | ||
Suggested Readings | 417 | ||
80 - Radiation Enteritis and Proctocolitis | 418 | ||
BACKGROUND | 418 | ||
PATHOPHYSIOLOGY | 418 | ||
PREDISPOSING RISK FACTORS | 418 | ||
GRADING SYSTEMS | 418 | ||
DIAGNOSTIC WORKUP | 418 | ||
PREVENTION | 419 | ||
MANAGEMENT OF RADIATION ENTERITIS | 419 | ||
Management of Radiation Injury to the Small Bowel | 419 | ||
Acute Radiation Enteritis | 419 | ||
Chronic Radiation Enteritis | 419 | ||
Management of Radiation Injury to the Colon | 420 | ||
Acute Radiation Colitis | 420 | ||
Chronic Radiation Colitis | 420 | ||
Management of Radiation Injury to the Rectum | 420 | ||
Topical Therapy | 421 | ||
Hyperbaric Oxygen | 421 | ||
Medical Therapy | 421 | ||
Endoscopic Management | 421 | ||
Surgery | 421 | ||
CONCLUSION | 422 | ||
Suggested Readings | 422 | ||
5 - COMPLICATIONS (AND OTHER MISCELLANEOUS TOPICS) | 425 | ||
81 - Colorectal Surgery in the High-Risk Patient | 427 | ||
INTRODUCTION | 427 | ||
IDENTIFICATION OF THE HIGH-RISK PATIENT | 427 | ||
MINIMIZING RISK ASSOCIATED WITH EMERGENCY SURGERY | 428 | ||
MINIMIZING RISK ASSOCIATED WITH CARDIAC DISEASE | 429 | ||
MINIMIZING RISK ASSOCIATED WITH PULMONARY DISEASE | 430 | ||
MINIMIZING RISK ASSOCIATED WITH IMMUNOSUPPRESSION | 431 | ||
Steroids | 431 | ||
Diabetes | 431 | ||
Chemoradiotherapy | 431 | ||
MINIMIZING RISK ASSOCIATED WITH MALNUTRITION | 432 | ||
MINIMIZING RISK ASSOCIATED WITH HEPATIC DISEASE | 432 | ||
MINIMIZING RISK ASSOCIATED WITH RENAL DISEASE | 433 | ||
MINIMIZING RISK IN MORBIDLY OBESE PATIENTS | 433 | ||
Suggested Reading | 433 | ||
82 - Reoperative Pelvic Surgery | 434 | ||
INTRODUCTION | 434 | ||
ANATOMIC FACTORS | 434 | ||
The Ureters | 434 | ||
Presacral Veins | 434 | ||
Pelvic Nerves | 434 | ||
POSTOPERATIVE CHANGES IN THE PELVIS | 434 | ||
Approach to Reoperative Pelvic Surgery | 434 | ||
Preoperative Planning | 434 | ||
Timing | 434 | ||
Patient Preparation | 435 | ||
Define the Anatomy | 435 | ||
Anticipate and Prepare for a Difficult Case | 435 | ||
Functional Considerations | 435 | ||
Intraoperative Conduct | 435 | ||
Patient Positioning | 435 | ||
Optimizing Visibility and Exposure | 435 | ||
Access to the Pelvis | 436 | ||
Identification of Specific Pelvic Structures | 436 | ||
Ureter | 436 | ||
Bladder | 436 | ||
Rectal Stump | 436 | ||
Vagina | 437 | ||
Autonomic Nerves | 437 | ||
Control of Bleeding | 437 | ||
Drainage | 437 | ||
SPECIFIC CLINICAL SITUATIONS | 437 | ||
Reversal of Hartmann Procedure for Diverticulitis | 437 | ||
Recurrent Rectal Cancer | 437 | ||
Redo Ileoanal Pelvic Pouch Procedure | 438 | ||
SUMMARY | 438 | ||
Suggested Reading | 438 | ||
83 - Nutritional Support in Colorectal Surgery | 439 | ||
INTRODUCTION | 439 | ||
NUTRITIONAL ASSESSMENT | 439 | ||
INDICATIONS FOR NUTRITIONAL SUPPORT | 439 | ||
General Indications | 439 | ||
Severe Malnutrition | 439 | ||
Postoperative Nutrition | 439 | ||
Specific CRS Indications | 440 | ||
Inflammatory Bowel Disease | 440 | ||
Colorectal Cancer | 440 | ||
ESTIMATION OF NUTRIENT REQUIREMENTS | 440 | ||
Calories | 440 | ||
Protein | 440 | ||
DIETARY COMPOSITION AND DELIVERY | 441 | ||
Hospital-Based Diets | 441 | ||
Clear Liquid Diet | 441 | ||
Regular Diet | 441 | ||
Low-Residue Diet | 441 | ||
Oral Supplements | 441 | ||
Liquid Formula Diets | 441 | ||
Enteral Nutrition | 441 | ||
Access for EN | 442 | ||
Early Postoperative Feeding: “Fast Track” | 443 | ||
Parenteral Nutrition | 443 | ||
Access for PN | 443 | ||
Concomitant EN and PN | 443 | ||
Overfeeding | 444 | ||
NEW DIRECTIONS | 444 | ||
Immunonutrition | 444 | ||
Preoperative Carbohydrate Loading | 444 | ||
SUMMARY | 444 | ||
Suggested Reading | 444 | ||
84 - Prevention and Management of Sepsis | 445 | ||
BACKGROUND | 445 | ||
PREVENTION | 445 | ||
Defining Risk | 445 | ||
Preventive Measures | 445 | ||
Bowel Preparation | 445 | ||
Prophylactic Antibiotics | 445 | ||
Intact Anastomosis | 445 | ||
Tension-Free Anastomosis | 445 | ||
Well-Vascularized Anastomosis | 445 | ||
Consideration for Diversion | 445 | ||
Appropriate Use of Drains | 446 | ||
MANAGEMENT OF INTRA-ABDOMINAL SEPSIS | 446 | ||
Goal-Directed Hemodynamic Support | 446 | ||
Evaluation | 446 | ||
Nonoperative Interventions | 446 | ||
Operation versus Observation | 447 | ||
Open Abdomen | 447 | ||
Return to the Operating Room | 447 | ||
Suggested Readings | 447 | ||
85 - Management of Anastomotic Leak | 448 | ||
INTRODUCTION | 448 | ||
WHAT DEFINES A LEAK? | 448 | ||
PRINCIPLES OF MANAGEMENT | 448 | ||
EARLY DIAGNOSIS | 448 | ||
IMAGING | 448 | ||
CRP LEVELS | 448 | ||
ENDOSCOPY | 449 | ||
VARIABLES DIRECTING MANAGEMENT | 449 | ||
Location: Intraperitoneal versus Extraperitoneal | 449 | ||
Type of Anastomosis: Ileocolic versus Colorectal/Ileorectal | 449 | ||
Symptoms: Sepsis versus Symptomatic versus Asymptomatic | 449 | ||
Previously Diverted: Proximal Diverting Ostomy versus Nondiverted | 450 | ||
LEAK MANAGEMENT TOOLS | 450 | ||
ENDO-VACUUM ASSISTED CLOSURE | 450 | ||
ENDOSCOPIC STENTS, CLIPS, AND GLUE | 450 | ||
TRANSANAL REPAIR TECHNIQUES | 451 | ||
TURNBULL-CUTAIT PULL THROUGH | 451 | ||
SUMMARY | 451 | ||
Suggested Reading | 451 | ||
86 - Complications of Colonoscopy | 452 | ||
INTRODUCTION | 452 | ||
RISK MANAGEMENT | 452 | ||
HEMORRHAGE | 452 | ||
Steps Prior to Colonoscopy | 452 | ||
Risk Factors for Bleeding | 453 | ||
Prevention of Bleeding | 453 | ||
Treatment of Bleeding | 453 | ||
PERFORATION | 454 | ||
Causes of Perforation | 454 | ||
Diagnosis of Perforation | 454 | ||
Management of Perforation | 454 | ||
Suggested Readings | 455 | ||
87 - Management of Hemorrhage during Pelvic Surgery | 456 | ||
INTRODUCTION | 456 | ||
PERTINENT ANATOMY | 456 | ||
BLEEDING | 458 | ||
TACTICS FOR CONTROL OF PELVIC BLEEDING | 458 | ||
Major Vessel Bleeding | 458 | ||
Iliac Vessels | 458 | ||
Minor Vessel Bleeding | 459 | ||
Presacral Bleeding | 459 | ||
Pelvic Packing | 459 | ||
Suture Ligation | 459 | ||
Thumbtacks | 459 | ||
Muscle Fragment Welding | 459 | ||
Bipolar Electrocautery | 459 | ||
Hemostasis Step-by-Step Technique | 460 | ||
Hemostatic Agents | 460 | ||
Mechanical Hemostatic Agents | 460 | ||
Active Hemostatic Agents | 460 | ||
Flowable Hemostatic Agents | 461 | ||
Fibrin Sealants | 461 | ||
CONCLUSION | 461 | ||
Selected Reading | 461 | ||
88 - Urologic Issues in Colorectal Surgery | 462 | ||
INTRODUCTION | 462 | ||
INFECTION | 462 | ||
URETER | 462 | ||
BLADDER | 463 | ||
URETHRA | 464 | ||
REPRODUCTIVE STRUCTURES | 465 | ||
NERVES | 465 | ||
BLOOD VESSELS | 467 | ||
Suggested Readings | 467 | ||
89 - Prevention and Treatment of Complications of Laparoscopic Colorectal Surgery | 468 | ||
INTRODUCTION | 468 | ||
GENERAL COMPLICATIONS | 468 | ||
Contraindications | 468 | ||
Peritoneal Access Complications | 468 | ||
Pneumoperitoneum Complications | 468 | ||
Thromboembolic Complications | 469 | ||
Electrosurgical Complications | 469 | ||
Positioning Complications | 469 | ||
Bleeding Complications | 469 | ||
Tumor Identification Difficulties | 470 | ||
Contamination | 470 | ||
Anastomosis Complications | 470 | ||
Urologic Complications | 471 | ||
CONCLUSIONS | 471 | ||
Suggested Reading | 471 | ||
90 - Prevention and Management of Ostomy Complications | 472 | ||
INTRODUCTION | 472 | ||
OSTOMY CREATION | 472 | ||
Preoperative Discussion and Consent | 472 | ||
Siting the Stoma | 472 | ||
Creating and Maturing the Stoma | 473 | ||
End Ileostomy | 474 | ||
Loop Ileostomy | 474 | ||
COMPLICATIONS | 474 | ||
Early Complications | 474 | ||
Appliance Issues/Skin Irritation | 474 | ||
Ischemia | 474 | ||
Stoma Stenosis | 475 | ||
Retraction | 475 | ||
Late Complications | 475 | ||
Parastomal Hernia | 475 | ||
Prolapse | 475 | ||
Stricture | 475 | ||
Peristomal Pyoderma | 475 | ||
Parastomal Ulcer | 475 | ||
Abscess and Fistula | 476 | ||
SUMMARY | 476 | ||
Suggested Reading | 476 | ||
91 - Stoma and Wound Considerations: Nursing Management | 477 | ||
PREOPERATIVE PREPARATION | 477 | ||
Preoperative Counseling | 477 | ||
Stoma Site Marking | 477 | ||
POSTOPERATIVE MANAGEMENT | 477 | ||
SPECIAL CONSIDERATIONS | 478 | ||
Continent ileostomy | 478 | ||
WOUND MANAGEMENT | 478 | ||
POSTDISCHARGE FOLLOW-UP | 478 | ||
COLOSTOMY IRRIGATION | 478 | ||
ILEOSTOMY LAVAGE | 484 | ||
CONCLUSION | 484 | ||
Suggested Readings | 485 | ||
92 - Measuring Outcomes | 486 | ||
INTRODUCTION | 486 | ||
TYPES OF OUTCOME MEASURES | 486 | ||
Structural Measures | 486 | ||
Process Measures | 486 | ||
Outcome Measures | 487 | ||
Person-Centered Outcomes | 487 | ||
MEASURING QUALITY OF LIFE | 487 | ||
Instruments for Assessing Quality of Life | 488 | ||
Colorectal Cancer Care | 488 | ||
Inflammatory Bowel Disease | 488 | ||
Fecal Incontinence | 488 | ||
Sexual Function | 488 | ||
CONSIDERATIONS IN CHOOSING OUTCOME MEASURES | 488 | ||
SUMMARY | 489 | ||
Suggested Readings | 489 | ||
93 - Medical Documentation and Coding for the Colorectal Surgeon | 490 | ||
INTRODUCTION | 490 | ||
PROCESS OF CPT CODE DEVELOPMENT | 490 | ||
CPT CODING FOR EVALUATION AND MANAGEMENT SERVICES | 490 | ||
Office Evaluation and Management Coding | 490 | ||
HOSPITAL-BASED EVALUATION AND MANAGEMENT DOCUMENTATION AND CODING | 491 | ||
CPT CODING FOR SURGICAL PROCEDURES | 492 | ||
SUMMARY | 492 | ||
Suggested Reading | 492 | ||
94 - Enhanced Recovery Pathways After Colorectal Surgery | 493 | ||
BACKGROUND | 493 | ||
COMPONENTS OF EVIDENCE-BASED CARE | 493 | ||
EVIDENCE FOR IMPROVED OUTCOME | 493 | ||
Colonic Surgery | 493 | ||
Rectal Surgery | 493 | ||
Other Colorectal Procedures | 493 | ||
IMPLEMENTATION STRATEGY AND TREATMENT ALGORITHM | 494 | ||
Colonic Surgery Protocol | 494 | ||
Rectal Surgery Protocol | 494 | ||
THE WAY FORWARD | 494 | ||
Suggested Readings | 495 | ||
95 - Managing Complex Ventral/Parastomal Hernias in Colorectal Surgical Patients | 496 | ||
INTRODUCTION | 496 | ||
PERMANENT ENTEROSTOMY—PARASTOMAL HERNIA REPAIR | 496 | ||
Open Repair | 496 | ||
Laparoscopic Repair | 497 | ||
TEMPORARY ENTEROSTOMY | 498 | ||
PROSTHETIC CHOICE | 498 | ||
HERNIA REPAIR IN INFLAMMATORY BOWEL DISEASE | 499 | ||
CONCLUSION | 500 | ||
Selected Reading | 500 | ||
Index | 501 | ||
A | 501 | ||
B | 502 | ||
C | 503 | ||
D | 506 | ||
E | 507 | ||
F | 507 | ||
G | 508 | ||
H | 508 | ||
I | 509 | ||
J | 510 | ||
K | 510 | ||
L | 510 | ||
M | 511 | ||
N | 511 | ||
O | 512 | ||
P | 512 | ||
Q | 514 | ||
R | 514 | ||
S | 515 | ||
T | 516 | ||
U | 517 | ||
V | 517 | ||
W | 518 | ||
Z | 518 | ||
IBC | ES2 |